BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37061716)

  • 1. Tumor lineage-specific immune response in brain metastatic disease: opportunities for targeted immunotherapy regimen?
    Najjary S; Kros JM; de Koning W; Vadgama D; Lila K; Wolf J; Mustafa DAM
    Acta Neuropathol Commun; 2023 Apr; 11(1):64. PubMed ID: 37061716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unlocking molecular mechanisms and identifying druggable targets in matched-paired brain metastasis of breast and lung cancers.
    Najjary S; de Koning W; Kros JM; Mustafa DAM
    Front Immunol; 2023; 14():1305644. PubMed ID: 38149244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of tumor immune microenvironment of EGFR/ALK-positive tumors versus EGFR/ALK-negative tumors in resected brain metastases from lung adenocarcinoma.
    Xiao G; Li L; Tanzhu G; Liu Z; Gao X; Wan X; Xiao D; Chen L; Xia X; Zhou R
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36868569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the Tumor Microenvironment toward Immune-Suppressive Seclusion during Brain Metastasis of Breast Cancer: Implications for Targeted Therapy.
    Noh MG; Kim SS; Kim YJ; Jung TY; Jung S; Rhee JH; Lee JH; Lee JS; Cho JH; Moon KS; Park H; Lee KH
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF is a prognostic biomarker involved in immune infiltration of lung adenocarcinoma and is associated with brain metastasis.
    Yu Q; Wang Y; Yi G; Yang W; Chen K; Tan X; Zhang X; Xu Z; Yang Z; Peng Y
    Immunology; 2023 Feb; 168(2):320-330. PubMed ID: 36151890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma.
    Shih DJH; Nayyar N; Bihun I; Dagogo-Jack I; Gill CM; Aquilanti E; Bertalan M; Kaplan A; D'Andrea MR; Chukwueke U; Ippen FM; Alvarez-Breckenridge C; Camarda ND; Lastrapes M; McCabe D; Kuter B; Kaufman B; Strickland MR; Martinez-Gutierrez JC; Nagabhushan D; De Sauvage M; White MD; Castro BA; Hoang K; Kaneb A; Batchelor ED; Paek SH; Park SH; Martinez-Lage M; Berghoff AS; Merrill P; Gerstner ER; Batchelor TT; Frosch MP; Frazier RP; Borger DR; Iafrate AJ; Johnson BE; Santagata S; Preusser M; Cahill DP; Carter SL; Brastianos PK
    Nat Genet; 2020 Apr; 52(4):371-377. PubMed ID: 32203465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentially expressed and survival-related proteins of lung adenocarcinoma with bone metastasis.
    Yang M; Sun Y; Sun J; Wang Z; Zhou Y; Yao G; Gu Y; Zhang H; Zhao H
    Cancer Med; 2018 Apr; 7(4):1081-1092. PubMed ID: 29522283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-purposing the pro-senescence properties of doxorubicin to introduce immunotherapy in breast cancer brain metastasis.
    Uceda-Castro R; Margarido AS; Cornet L; Vegna S; Hahn K; Song JY; Putavet DA; van Geldorp M; Çitirikkaya CH; de Keizer PLJ; Ter Beek LC; Borst GR; Akkari L; van Tellingen O; Broekman MLD; Vennin C; van Rheenen J
    Cell Rep Med; 2022 Nov; 3(11):100821. PubMed ID: 36384097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma.
    Wang Z; Wang Y; Chang M; Wang Y; Liu P; Wu J; Wang G; Tang X; Hui X; Liu P; Guo X; Xing B; Wang Y; Han Z; Ma W
    Neuro Oncol; 2023 Jul; 25(7):1262-1274. PubMed ID: 36656750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of prolyl 4-hydroxylase subunit alpha-2 in lung adenocarcinoma indicates poor prognosis.
    Lu XH; Sang D; Zhang YR; Yuan Q
    Clinics (Sao Paulo); 2022; 77():100123. PubMed ID: 36403427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.
    Yang L; He YT; Dong S; Wei XW; Chen ZH; Zhang B; Chen WD; Yang XR; Wang F; Shang XM; Zhong WZ; Wu YL; Zhou Q
    J Immunother Cancer; 2022 Jan; 10(2):. PubMed ID: 35140113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Expression of
    Chen Y; Zhou M; Gu X; Wang L; Wang C
    Dis Markers; 2022; 2022():8789515. PubMed ID: 35855850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analysis of Lung Adenocarcinoma and Brain Metastasis through Integrated Single-Cell Transcriptomics.
    Souza VGP; Telkar N; Lam WL; Reis PP
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.
    Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J
    Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy.
    Liao Y; He D; Wen F
    Immunogenetics; 2021 Oct; 73(5):369-380. PubMed ID: 34302518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer.
    Tsakonas G; Lewensohn R; Botling J; Ortiz-Villalon C; Micke P; Friesland S; Nord H; Lindskog M; Sandelin M; Hydbring P; Ekman S
    Eur J Cancer; 2020 Jun; 132():24-34. PubMed ID: 32325417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CILP, a Putative Gene Associated With Immune Infiltration in Breast Cancer Brain Metastases.
    Sun X; Yang N; Zhou X; Dai H; Li Q; Feng A; Xu G; Liu Y; Xu L; Zhang Z; Yang Z; Li X
    Front Genet; 2022; 13():862264. PubMed ID: 35711946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct cellular immune profiles in lung adenocarcinoma manifesting as pure ground glass opacity versus solid nodules.
    Qu R; Ye F; Hu S; Wang B; Qin S; Xiong J; Fu X; Li L; Cai Y
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3775-3788. PubMed ID: 35986758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
    Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
    Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.